DNA2.0 has been the industry leader in Synthetic Biology Solutions for over a decade. Their products, consultants and services enable researchers worldwide to achieve their goals. With significant industry experience in fields such as molecular biology, bioinformatics, technology development and research leadership, the company's senior management team uniquely positions DNA2.0 as an industry-leading enabler of visionary products and services. DNA2.0’s visionary biotech leadership has improved the way people research, create and live, one gene at a time.
DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique
competences in Life Sciences and Materials Sciences DSM is
driving economic prosperity, environmental progress and
social advances to create sustainable value for all
stakeholders. DSM delivers innovative solutions that
nourish, protect and improve performance in global markets
such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints,
electrical and electronics, life protection, alternative
energy and bio-based materials. DSM's 22,000 employees
deliver annual net sales of around EUR9 billion. The
company is listed on NYSE Euronext. More information can be
found at www.dsm.com.